MELBOURNE, Australia—A clinical trials and pharmaceutical regulation affairs expert has urged Australia’s Therapeutic Goods Administration (TGA) to suspend the “provisional approval” status granted to COVID-19 vaccines and declared Australia’s drug adverse event reporting system “broken.”
This comes after the TGA reported 135,978 cases of total adverse events following COVID-19 immunisations to Sept. 4. The TGA has also identified 13 reports where the cause of death was “linked” to vaccinations from the 937 reports it received and reviewed.
Speaking at a conference hosted by the Australian Medical Professionals’ Society (AMPS) named “Reclaiming Medicine” in Melbourne on Sept. 10, Dr. Phillip Altman—a veteran and expert in the areas of clinical medical research and pharmaceutical drug regulatory affairs in Australia—said the number of cases could be higher….